# Voyager Technologies, Inc.: financial statements, quarterly

VOYG · NYSE · CIK 1788060 · [Industrials](/sectors/industrials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/voyg.md) · [Financials](/companies/voyg/financials.md) · [Filings](/companies/voyg/filings.md) · [Insiders](/companies/voyg/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/voyg/financials.md?period=annual).

## Income statement

| Line item | Unit | period not labelled (2024-06-30) | period not labelled (2024-09-30) | period not labelled (2024-12-31) | period not labelled (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [36.7](/filings/0001788060-25-000013.md) | [39.6](/filings/0001628280-25-048679.md) | [37.7 d](/filings/0001628280-26-016543.md) | [34.5](/filings/0001628280-26-030331.md) | [45.7](/filings/0001628280-26-052292.md) | [39.6](/filings/0001628280-25-048679.md) | [46.7 d](/filings/0001628280-26-016543.md) | [35.2](/filings/0001628280-26-030331.md) | [52.7](/filings/0001628280-26-052292.md) |
| Cost of revenue | $m | [27.4](/filings/0001788060-25-000013.md) | [30.3](/filings/0001628280-25-048679.md) | [27.6 d](/filings/0001628280-26-016543.md) | [28.9](/filings/0001628280-26-030331.md) | [37.5](/filings/0001628280-26-052292.md) | [33.5](/filings/0001628280-25-048679.md) | [36.7 d](/filings/0001628280-26-016543.md) | [36.8](/filings/0001628280-26-030331.md) | [48.3](/filings/0001628280-26-052292.md) |
| Gross profit | $m | not reported | not reported | not reported | [5.6](/filings/0001628280-26-030331.md) | [8.2](/filings/0001628280-26-052292.md) | not reported | not reported | [(1.5)](/filings/0001628280-26-030331.md) | [4.5](/filings/0001628280-26-052292.md) |
| Research and development | $m | [6.9](/filings/0001788060-25-000013.md) | not reported | not reported | [4.0](/filings/0001628280-26-030331.md) | [0.5](/filings/0001628280-26-052292.md) | not reported | not reported | [7.5](/filings/0001628280-26-030331.md) | [7.3](/filings/0001628280-26-052292.md) |
| Selling, general and administrative | $m | [13.3](/filings/0001788060-25-000013.md) | [15.2](/filings/0001628280-25-048679.md) | [18.5 d](/filings/0001628280-26-016543.md) | [26.3](/filings/0001628280-26-030331.md) | [30.2](/filings/0001628280-26-052292.md) | [25.1](/filings/0001628280-25-048679.md) | [35.5 d](/filings/0001628280-26-016543.md) | [31.4](/filings/0001628280-26-030331.md) | [43.7](/filings/0001628280-26-052292.md) |
| Operating income | $m | [(12.6)](/filings/0001788060-25-000013.md) | [(12.1)](/filings/0001628280-25-048679.md) | [(11.8) d](/filings/0001628280-26-016543.md) | [(26.3)](/filings/0001628280-26-030331.md) | [(24.1)](/filings/0001628280-26-052292.md) | [(24.0)](/filings/0001628280-25-048679.md) | [(34.0) d](/filings/0001628280-26-016543.md) | [(44.6)](/filings/0001628280-26-030331.md) | [(51.4)](/filings/0001628280-26-052292.md) |
| Interest expense | $m | [3.1](/filings/0001788060-25-000013.md) | [2.9](/filings/0001628280-25-048679.md) | [3.0 d](/filings/0001628280-26-016543.md) | [2.7](/filings/0001628280-26-030331.md) | [2.5](/filings/0001628280-26-052292.md) | [0.2](/filings/0001628280-25-048679.md) | [1.4 d](/filings/0001628280-26-016543.md) | [2.1](/filings/0001628280-26-030331.md) | [1.9](/filings/0001628280-26-052292.md) |
| Income tax | $m | [(0.1)](/filings/0001788060-25-000013.md) | [0.1](/filings/0001628280-25-048679.md) | [(1.9) d](/filings/0001628280-26-016543.md) | [0.0](/filings/0001628280-26-030331.md) | [0.1](/filings/0001628280-26-052292.md) | [(1.8)](/filings/0001628280-25-048679.md) | [1.2 d](/filings/0001628280-26-016543.md) | [3.2](/filings/0001628280-26-030331.md) | [(2.2)](/filings/0001628280-26-052292.md) |
| Net income | $m | [(23.3)](/filings/0001788060-25-000013.md) | [(15.0)](/filings/0001628280-25-048679.md) | [(9.0) d](/filings/0001628280-26-016543.md) | [(26.9)](/filings/0001628280-26-030331.md) | [(31.4)](/filings/0001628280-26-052292.md) | [(16.3)](/filings/0001628280-25-048679.md) | [(30.2) d](/filings/0001628280-26-016543.md) | [(44.0)](/filings/0001628280-26-030331.md) | [(46.5)](/filings/0001628280-26-052292.md) |
| Diluted EPS | $ per share | [(2.73)](/filings/0001788060-25-000013.md) | [(1.61)](/filings/0001628280-25-048679.md) | not reported | [(2.30)](/filings/0001628280-26-030331.md) | [(1.23)](/filings/0001628280-26-052292.md) | [(0.28)](/filings/0001628280-25-048679.md) | not reported | [(0.75)](/filings/0001628280-26-030331.md) | [(0.79)](/filings/0001628280-26-052292.md) |
| Basic EPS | $ per share | [(2.29)](/filings/0001788060-25-000013.md) | [(1.61)](/filings/0001628280-25-048679.md) | not reported | [(2.30)](/filings/0001628280-26-030331.md) | [(1.23)](/filings/0001628280-26-052292.md) | [(0.28)](/filings/0001628280-25-048679.md) | not reported | [(0.75)](/filings/0001628280-26-030331.md) | [(0.79)](/filings/0001628280-26-052292.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfGoodsAndServicesSold
- Gross profit: us-gaap:GrossProfit
- Research and development: us-gaap:ResearchAndDevelopmentExpense
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | period not labelled (2022-12-31) | period not labelled (2023-12-31) | period not labelled (2024-03-31) | period not labelled (2024-06-30) | period not labelled (2024-09-30) | period not labelled (2024-12-31) | period not labelled (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | not reported | not reported | not reported | not reported | not reported | [55.9](/filings/0001628280-26-016543.md) | not reported | [469](/filings/0001788060-25-000013.md) | [413](/filings/0001628280-25-048679.md) | [491](/filings/0001628280-26-052292.md) | [429](/filings/0001628280-26-030331.md) | [373](/filings/0001628280-26-052292.md) |
| Current assets | $m | not reported | not reported | not reported | not reported | not reported | [102](/filings/0001628280-26-016543.md) | not reported | [511](/filings/0001788060-25-000013.md) | [481](/filings/0001628280-25-048679.md) | [581](/filings/0001628280-26-052292.md) | [509](/filings/0001628280-26-030331.md) | [486](/filings/0001628280-26-052292.md) |
| Total assets | $m | not reported | not reported | not reported | not reported | not reported | [248](/filings/0001628280-26-016543.md) | not reported | [685](/filings/0001788060-25-000013.md) | [728](/filings/0001628280-25-048679.md) | [1,050](/filings/0001628280-26-052292.md) | [1,024](/filings/0001628280-26-030331.md) | [1,009](/filings/0001628280-26-052292.md) |
| Current liabilities | $m | not reported | not reported | not reported | not reported | not reported | [87.4](/filings/0001628280-26-016543.md) | not reported | [91.3](/filings/0001788060-25-000013.md) | [97.9](/filings/0001628280-25-048679.md) | [133](/filings/0001628280-26-052292.md) | [111](/filings/0001628280-26-030331.md) | [128](/filings/0001628280-26-052292.md) |
| Total liabilities | $m | not reported | not reported | not reported | not reported | not reported | [188](/filings/0001628280-26-016543.md) | not reported | [103](/filings/0001788060-25-000013.md) | [109](/filings/0001628280-25-048679.md) | [621](/filings/0001628280-26-052292.md) | [619](/filings/0001628280-26-030331.md) | [633](/filings/0001628280-26-052292.md) |
| Shareholders' equity | $m | [(68.2)](/filings/0001628280-26-016543.md) | [(92.6)](/filings/0001628280-26-016543.md) | [(82.7)](/filings/0001788060-25-000013.md) | [(78.7)](/filings/0001628280-25-048679.md) | [(87.1)](/filings/0001628280-25-048679.md) | [(69.7)](/filings/0001628280-26-016543.md) | [49.8](/filings/0001628280-26-052292.md) | [555](/filings/0001788060-25-000013.md) | [591](/filings/0001628280-25-048679.md) | [384](/filings/0001628280-26-052292.md) | [357](/filings/0001628280-26-030331.md) | [326](/filings/0001628280-26-052292.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Shareholders' equity: us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest, us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | period not labelled (2024-09-30) | period not labelled (2024-12-31) | period not labelled (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [(0.9) d](/filings/0001628280-25-048679.md) | [(5.5) d](/filings/0001628280-26-016543.md) | [(14.4)](/filings/0001628280-26-030331.md) | [(16.5) d](/filings/0001628280-26-052292.md) | [(15.1) d](/filings/0001628280-25-048679.md) | [(15.0) d](/filings/0001628280-26-016543.md) | [(39.7)](/filings/0001628280-26-030331.md) | [(44.3) d](/filings/0001628280-26-052292.md) |
| Capital expenditure | $m | [20.4 d](/filings/0001628280-25-048679.md) | [29.9 d](/filings/0001628280-26-016543.md) | [27.0](/filings/0001628280-26-030331.md) | [30.9 d](/filings/0001628280-26-052292.md) | [38.7 d](/filings/0001628280-25-048679.md) | [48.1 d](/filings/0001628280-26-016543.md) | [51.1](/filings/0001628280-26-030331.md) | [35.5 d](/filings/0001628280-26-052292.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment

## Shares

| Line item | Unit | period not labelled (2024-06-30) | period not labelled (2024-09-30) | period not labelled (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [12.6](/filings/0001788060-25-000013.md) | [12.7](/filings/0001628280-25-048679.md) | [14.3](/filings/0001628280-26-030331.md) | [29.7](/filings/0001628280-26-052292.md) | [58.4](/filings/0001628280-25-048679.md) | [58.3](/filings/0001628280-26-030331.md) | [58.5](/filings/0001628280-26-052292.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:47 ET. No prices; not investment advice.